GENESEE VALLEY TRUST CO - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 143 filers reported holding NEKTAR THERAPEUTICS in Q3 2013. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
GENESEE VALLEY TRUST CO ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2018$200,000
-23.4%
2,314
-47.0%
0.08%
-25.7%
Q4 2017$261,000
-1.5%
4,366
-60.5%
0.11%
+0.9%
Q3 2017$265,000
+21.0%
11,061
-1.1%
0.11%
+16.1%
Q2 2017$219,000
-17.4%
11,181
-1.1%
0.09%
-48.9%
Q1 2017$265,000
+89.3%
11,306
-0.9%
0.18%
+83.8%
Q4 2016$140,000
-33.0%
11,414
-6.4%
0.10%
-22.7%
Q3 2016$209,000
+20.8%
12,189
+0.4%
0.13%
+14.3%
Q2 2016$173,000
+9.5%
12,135
+5.7%
0.11%
+4.7%
Q1 2016$158,000
-27.5%
11,485
-11.0%
0.11%
-25.2%
Q4 2015$218,000
+53.5%
12,910
-0.2%
0.14%
+52.1%
Q3 2015$142,000
-10.1%
12,940
+2.2%
0.09%
-7.8%
Q2 2015$158,000
+11.3%
12,660
-2.1%
0.10%
+15.9%
Q1 2015$142,000
-29.0%
12,925
+0.3%
0.09%
-31.2%
Q4 2014$200,000
-9.1%
12,885
-29.4%
0.13%
-6.6%
Q3 2014$220,000
-4.8%
18,250
+1.2%
0.14%
-1.4%
Q2 2014$231,000
+5.5%
18,040
-0.3%
0.14%
+0.7%
Q1 2014$219,000
+5.8%
18,100
-0.8%
0.14%
+0.7%
Q4 2013$207,000
+8.9%
18,250
+0.5%
0.14%
-2.1%
Q3 2013$190,000
-10.4%
18,160
-0.9%
0.14%
-15.7%
Q2 2013$212,00018,3200.17%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2013
NameSharesValueWeighting ↓
TIRSCHWELL & LOEWY INC 588,908$7,138,0001.23%
Granahan Investment Management 3,693,956$44,771,0001.21%
NEA Management Company, LLC 1,825,600$22,126,0001.09%
FIC CAPITAL INC 150,868$1,829,0000.75%
Rhenman & Partners Asset Management AB 181,797$2,203,0000.66%
SOPHROSYNE CAPITAL LLC 60,200$728,0000.64%
HARVEY CAPITAL MANAGEMENT INC 130,400$1,580,0000.63%
Artal Group S.A. 1,300,000$15,756,0000.57%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 564,418$6,840,0000.47%
OppenheimerFunds, Inc. 24,400,000$295,728,0000.35%
View complete list of NEKTAR THERAPEUTICS shareholders